LEADER 02966nam  2200565Ia 450 
001 9910876704803321
005 20200520144314.0
010   $a1-281-06963-9
010   $a9786611069636
010   $a0-470-69252-9
010   $a0-470-76604-2
035   $a(CKB)1000000000414459
035   $a(EBL)320041
035   $a(OCoLC)476116332
035   $a(SSID)ssj0000104115
035   $a(PQKBManifestationID)11131010
035   $a(PQKBTitleCode)TC0000104115
035   $a(PQKBWorkID)10078522
035   $a(PQKB)11293551
035   $a(MiAaPQ)EBC320041
035   $a(EXLCZ)991000000000414459
100   $a20070607d2007      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAntiarrhythmic drugs $ea practical guide /$fRichard N. Fogoros
205   $a2nd ed.
210   $aOxford $cBlackwell Futura$d2007
215   $a1 online resource (194 p.)
300   $aPrevious ed.: New York: Blackwell Science, 1997.
311   $a1-4051-6351-8 
320   $aIncludes bibliographical references and index.
327   $aAntiarrhythmic Drugs; Contents; Preface; Acknowledgments; Part 1 Basic principles; Chapter 1 Mechanisms of cardiac tachyarrhythmias; Chapter 2 Introduction to antiarrhythmic drugs; Part 2 Clinical features of antiarrhythmic drugs; Chapter 3 Class I antiarrhythmic drugs; Chapter 4 Class II antiarrhythmic drugs;  beta-blocking agents; Chapter 5 Class III antiarrhythmic drugs; Chapter 6 Class IV drugs: calcium-blocking agents; Chapter 7 Unclassified antiarrhythmic agents; Chapter 8 Investigational antiarrhythmic drugs; Chapter 9 Common adverse events with antiarrhythmic drugs
327   $aPart 3 Antiarrhythmic drugs in the treatment of cardiac arrhythmias Chapter 10 Basic principles of using antiarrhythmic drugs; Chapter 11 Treatment of supraventricular tachyarrhythmias; Chapter 12 Treatment of ventricular arrhythmias; Chapter 13 Treatment of arrhythmias in pregnancy; Index
330   $aIf you prescribe for patients with arrhythmias, you will want to keep this valuable paperback close at hand. The Second Edition of this valuable reference responds to changes in the available medications as well as in the way they are currently used.  The book reviews everything you need to understand and prescribe today's antiarrhythmic drugs: mechanisms of cardiac arrhythmias and how antiarrhythmic drugs alter those arrhythmias, including common adverse effects which factors to consider in using these drugs for treatment of supraventricular tachyarrh
606   $aMyocardial depressants
606   $aInternal medicine
615  0$aMyocardial depressants.
615  0$aInternal medicine.
676   $a615.716
700   $aFogoros$b Richard N$0854280
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910876704803321
996   $aAntiarrhythmic drugs$92230651
997   $aUNINA